Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The British Society for Rheumatology biologics register.

K Watson1, D Symmons, I Griffiths

  • 1Epidemiology Research Unit, Manchester University Medical School, Manchester, UK.

Annals of the Rheumatic Diseases
|October 22, 2005
PubMed
Summary

The British Society for Rheumatology (BSR) created a national biologic agent register to track long-term toxicity and benefits in rheumatological disorders. This prospective study includes a comparison group for comprehensive analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing longitudinal patterns of central and peripheral insulin resistance.

Psychoneuroendocrinology·2025
Same author

Preventing cancer in firefighters: lessons from the Grenfell Tower fire.

Occupational medicine (Oxford, England)·2025
Same author

Towards the identification of transmission pathways and early detection of Enterococcus cecorum infection in broiler chickens.

Poultry science·2024
Same author

Age, Gender, and Liver Enzyme Impact Hospital Stay in COVID-19 Minority Patient with Cancer in the USA: Does Race Matters in the Pandemic?

Annals of clinical and medical case reports·2024
Same author

Treatment of enterocutaneous fistula: a systematic review and meta-analysis.

Techniques in coloproctology·2022
Same author

The impact of BMI and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data.

Osteoarthritis and cartilage·2019

Area of Science:

  • Rheumatology
  • Clinical Pharmacology
  • Public Health

Background:

  • Biologic agents are increasingly used for rheumatological disorders.
  • Long-term safety and efficacy data in routine practice are crucial.
  • A need exists for comparative data between biologic and conventional therapies.

Purpose of the Study:

  • To establish a national prospective registry for patients on biologic agents.
  • To assess the long-term toxicity of biologic agents in routine rheumatological care.
  • To evaluate the benefits of biologic agents relative to their toxicity.

Main Methods:

  • Prospective, nationwide data collection via the British Society for Rheumatology (BSR) register.
  • Inclusion of a parallel comparison group with rheumatoid arthritis on conventional disease-modifying agents.

Related Experiment Videos

  • Planned class-specific and drug-specific analyses for biologic agents.

    • Main Results:

    • Data collection initiated for a national cohort of patients on biologic therapies.
    • Establishment of a comparison cohort receiving conventional treatments.
    • Framework in place for detailed safety and efficacy analyses.

    Conclusions:

    • The BSR register provides a robust platform for evaluating biologic agent use in rheumatology.
    • Long-term monitoring will inform clinical practice regarding safety and benefit-risk profiles.
    • Comparative data will enhance understanding of treatment strategies for rheumatological conditions.